Kondrat'eva E I, Matveeva L A, Shemyakina T A, Logvinenko Yu I, Golikova E V, Kutuzova E B
Siberian State Medical Universoty, Federal Agency for Health Care and Social Development, Tomsk.
Bull Exp Biol Med. 2009 Aug;148(2):266-9. doi: 10.1007/s10517-009-0704-y.
Anaferon (pediatric formulation) reduces the incidence of acute respiratory viral infections in sickly children and children with bronchial asthma and has a positive effect on the course of asthma. The preparation produces an immunomodulating effect (increases initially low IFN-gamma levels and normalizes elevated levels of IL-1beta), stimulates synthesis of IgA and IgG, exhibits cytoprotective activity, and improves local immunity of the upper airways in sickly children.
安纳法隆（儿科制剂）可降低体弱儿童和支气管哮喘儿童急性呼吸道病毒感染的发生率，并对哮喘病程产生积极影响。该制剂具有免疫调节作用（最初可提高低水平的γ-干扰素并使升高的白细胞介素-1β水平恢复正常），刺激免疫球蛋白A和免疫球蛋白G的合成，具有细胞保护活性，并可改善体弱儿童上呼吸道的局部免疫力。
